Randomized Clinical Trial of Adjuvant Mitomycin Plus Tegafur in Patients With Resected Stage III Gastric Cancer

Luis Cirera, A. Balil, E. Batiste-Alentorn, +6

Journal of Clinical Oncology

The EMECAM project: a multicentre study on air pollution and mortality in Spain: combined results for particulates and for sulfur dioxide

Ferrán Ballester, Marc Sáez, Santiago Pérez‐Hoyos, +14

Occupational and Environmental Medicine

Anticachectic Efficacy of Megestrol Acetate at Different Doses and Versus Placebo in Patients With Neoplastic Cachexia

Catalina Vadell, Miguel Ángel Seguí, José María Giménez-Arnau, +8

American Journal of Clinical Oncology

Small Cell Carcinoma of the Urinary Bladder Treated with Chemotherapy and Radiotherapy: Results in Five Cases

R. Bast uacute s, Javier Martínez Caballero, G. Gonz aacute lez, +6

European Urology

Urological ResearchSurgical OncologyUrologyUrologic Cancer EpidemiologyGenitourinary Cancer +5

Practical prognostic index for patients with metastatic recurrent breast cancer: retrospective analysis of 2,322 patients from the GEICAM Spanish El Alamo Register

Javier Puente, Sara López‐Tarruella, Aňa Lluch, +11

Breast Cancer Research and Treatment

Prognostic AssessmentPrognostic EvaluationBreast OncologyPractical Prognostic IndexMedicine +8

miR-21, miR-99b and miR-375 combination as predictive response signature for preoperative chemoradiotherapy in rectal cancer

Marc Campayo, Alfons Navarro, José Carlos Benítez, +4

PLoS ONE

Biweekly cetuximab in combination with FOLFOX-4 in the first-line treatment of wild-type KRASmetastatic colorectal cancer: final results of a phase II, open-label, clinical trial (OPTIMIX-ACROSS Study)

Julen Fernández-Plana, Carles Pericay, Guillermo Quintero, +6

BMC Cancer

Cetuximab Given Every 2 Weeks plus Irinotecan Is an Active and Safe Option for Previously Treated Patients with Metastatic Colorectal Cancer

J. M. Roca, Vicente Alonso, Carles Pericay, +17

Chemotherapy

Routine positron emission tomography (PET) and selective mediastinoscopy is as good as routine mediastinoscopy to rule out N2 disease in non-small cell lung cancer (NSCLC)

Mireia Serra, Luis Cirera, Ramón Rami–Porta, +7

Journal of Clinical Oncology

Surgical OncologyOncologic ImagingAdvanced Lung DiseasePathologyInterventional Radiology +16

Primary hormonal therapy with exemestane in patients with breast tumors >3 cm in diameter: Results of a Spanish multicenter phase II trial

Miguel Gil‐Gil, Agustí Barnadas, Luis Cirera, +4

Journal of Clinical Oncology

Surgical OncologyBreast OncologyBreast Cancer TumorCancer ManagementGynecology +17